Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chris Fellner"'
Autor:
Lunawati L, Bennett, Chris, Fellner
Publikováno v:
PT : a peer-reviewed journal for formulary management. 43(5)
The clinical manifestations of Gaucher disease, a rare genetic lysosomal storage disorder, are debilitating, and the neuronopathic forms of the disease are fatal. The authors describe the current and investigational therapies for treatment.
Autor:
Chris Fellner
Dracula and Frankenstein. Christopher Lee and Peter Cushing. These are just a few of the icons of Hammer Films. To horror fans, the name “Hammer” conjures visions of hissing vampires and buxom beauties in low-cut negligees. But Britain's Hammer F
Autor:
Lyn K, Chesna, Chris, Fellner
Publikováno v:
PT : a peer-reviewed journal for formulary management. 42(10)
Analysts have identified several unmet needs in the HIV therapy marketplace. We present the promising candidates in late-stage clinical development or FDA review.
Autor:
Chris, Fellner
Publikováno v:
PT : a peer-reviewed journal for formulary management. 42(6)
We review the immunomodulatory agents in development for systemic lupus erythematosus, a relatively uncommon disorder affecting women of childbearing age.
Publikováno v:
Technology, Pedagogy and Education. 23:19-37
This paper centres around a discussion of the design and rebuild of a secondary school in Birmingham (England) as part of the Building Schools of the Future (BSF) Programme. The BSF Programme was influenced by a vision of future schooling in which le
Autor:
Chris, Fellner
Publikováno v:
PT : a peer-reviewed journal for formulary management. 41(10)
Patients with type-2 diabetes can control their blood glucose levels through diet and exercise, by losing excess weight, and by taking medications, such as first-line metformin. We examine several promising drugs in the type-2 diabetes pipeline.
Autor:
Chris, Fellner
Publikováno v:
PT : a peer-reviewed journal for formulary management. 41(3)
Emtricitabine/rilpivirine/tenofovir alafenamide (Odefsey) for combination HIV-1 therapy; dapsone gel, 7.5% (Aczone) for acne vulgaris; extended-release tofacitinib (Xeljanz XR) for rheumatoid arthritis; and brivaracetam (Briviact) for epilepsy.
Autor:
Chris, Fellner
Publikováno v:
PT : a peer-reviewed journal for formulary management. 41(2)
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most widespread and virulent nosocomial pathogens. The late-stage clinical pipeline includes an array of proposed new treatments aimed at MRSA-related skin infections and pneumonia.
Publikováno v:
PT : a peer-reviewed journal for formulary management. 40(7)
Sodium-glucose linked transporter 2 inhibitors limit the reabsorption of glucose from glomerular filtrate in the kidneys, reducing blood glucose levels in patients with type- 2 diabetes. This article is meant to evaluate this class of medications for
Publikováno v:
PT : a peer-reviewed journal for formulary management. 40(6)
Pain modulation is a key treatment goal for diabetic peripheral neuropathy patients. Guidelines have recommended antidepressant, anticonvulsant, analgesic, and topical medications—both approved and off-label—to reduce pain in this population.